The IQ Candriam Healthy Hearts Index is a global modified market-cap weighted index that consists of the top-rated companies making a positive contribution to global health-related goals, including by providing solutions for monitoring and curing heart diseases and helping people adopt a healthy lifestyle that limits cardiovascular risks.
Mutual Fund to ETF Converter Tool
We’re sorry, there are no active ETFs associated with this index.
Sort By:
ETF Database staff has allocated each ETF in the ETF database, as well as each index, to a single ‘best-fit’ ETF Database Category. Other ETFs in the Health & Biotech Equities ETF Database Category are presented in the following table.
* Assets in thousands of U.S. Dollars.
Historical return data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Fund flow information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Expense information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Dividend information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Holdings data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Tax Rate data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Technical information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to analysis of other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to a proprietary ETF Database rating for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
| Symbol | ETF Name | Asset Class | Total Assets* | YTD | Avg Volume | Previous Closing Price | 1-Day Change | Overall Rating | 1 Week | 1 Month | 1 Year | 3 Year | 5 Year | YTD FF | 1 Week FF | 4 Week FF | 1 Year FF | 3 Year FF | 5 Year FF | ETF Database | Inception | ER | Commission Free | Annual Dividend Rate | Dividend Date | Dividend | Annual Dividend Yield % | P/E Ratio | Beta | # of Holdings | % In Top 10 | Complete | ST Cap Gain Rate | LT Cap Gain Rate | Tax Form | Lower Bollinger | Upper Bollinger | Support 1 | Resistance 1 | RSI | Advanced | Fact Sheet | ETF Holdings | Chart | ETF Home Page | Head-To-Head | Liquidity Rating | Expenses Rating | Returns Rating | Volatility Rating | Dividend Rating | Concentration Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | Equity | $37,261,600 | -5.0% | 11,801,457.0 | $146.40 | -0.97% | -1.4% | 0.8% | 12.3% | 6.2% | 5.5% | Health & Biotech Equities | 1998-12-16 | 0.08% | N/A | $2.51 | 2026-03-23 | $0.60 | 1.71% | 17.9 | 0.58 | 62 | 60.5% | View | 40% | 20% | 1099 | $142.87 | $150.73 | $145.38 | $147.34 | 47.91 | View | View | View | View | View | View | A | A | |||||||||||
| VHT | Vanguard Health Care ETF | Equity | $16,385,800 | -4.8% | 201,182.0 | $272.98 | -1.21% | -1.6% | 0.6% | 13.7% | 6.3% | 4.4% | Health & Biotech Equities | 2004-01-26 | 0.09% | Vanguard | $4.70 | 2026-03-24 | $0.99 | 1.72% | 26.8 | 0.62 | 403 | 50.5% | View | 40% | 20% | 1099 | $267.59 | $281.10 | $271.32 | $274.72 | 47.57 | View | View | View | View | View | View | A | A | |||||||||||
| XBI | State Street SPDR S&P Biotech ETF | Equity | $8,132,860 | 4.8% | 9,153,248.0 | $127.76 | -4.39% | -4.2% | -2.0% | 57.8% | 14.7% | 0.3% | Health & Biotech Equities | 2006-01-31 | 0.35% | N/A | $0.44 | 2025-12-22 | $0.41 | 0.35% | 18.8 | 0.85 | 145 | 15.6% | View | 40% | 20% | 1099 | $127.88 | $138.53 | $126.23 | $130.63 | 44.56 | View | View | View | View | View | View | A+ | A | |||||||||||
| IBB | iShares Biotechnology ETF | Equity | $7,763,410 | -2.6% | 1,542,938.0 | $164.27 | -3.01% | -3.0% | -1.8% | 33.1% | 9.3% | 2.0% | Health & Biotech Equities | 2001-02-05 | 0.44% | N/A | $0.39 | 2026-03-17 | $0.12 | 0.24% | 23.2 | 0.72 | 244 | 45.2% | View | 40% | 20% | 1099 | $164.41 | $174.60 | $162.85 | $166.75 | 42.66 | View | View | View | View | View | View | A | B | |||||||||||
| IXJ | iShares Global Healthcare ETF | Equity | $3,611,250 | -5.6% | 175,628.0 | $91.92 | -1.14% | -2.2% | -0.5% | 8.6% | 4.7% | 4.1% | Health & Biotech Equities | 2001-11-13 | 0.40% | N/A | $1.36 | 2025-12-16 | $0.60 | 1.48% | 23.7 | 0.58 | 115 | 48.0% | View | 40% | 20% | 1099 | $91.02 | $95.10 | $91.42 | $92.36 | 44.05 | View | View | View | View | View | View | A | B+ | |||||||||||
| IYH | iShares U.S. Healthcare ETF | Equity | $3,075,580 | -5.1% | 755,198.0 | $61.59 | -1.14% | -1.5% | 0.8% | 12.3% | 5.5% | 4.4% | Health & Biotech Equities | 2000-06-12 | 0.38% | N/A | $0.81 | 2026-03-17 | $0.20 | 1.31% | 25.3 | 0.59 | 104 | 58.8% | View | 40% | 20% | 1099 | $60.14 | $63.40 | $61.20 | $61.97 | 48.08 | View | View | View | View | View | View | B+ | B+ | |||||||||||
| IHI | iShares U.S. Medical Devices ETF | Equity | $2,960,670 | -22.4% | 2,496,226.0 | $48.19 | -1.33% | -4.3% | -4.6% | -21.5% | -3.0% | -2.6% | Health & Biotech Equities | 2006-05-01 | 0.38% | N/A | $0.22 | 2026-03-17 | $0.04 | 0.46% | 29.0 | 0.83 | 49 | 75.1% | View | 40% | 20% | 1099 | $47.78 | $51.00 | $47.75 | $48.63 | 36.49 | View | View | View | View | View | View | A | A- | |||||||||||
| FHLC | Fidelity MSCI Health Care Index ETF | Equity | $2,954,120 | -4.7% | 180,815.0 | $70.57 | -1.25% | -1.6% | 0.7% | 13.8% | 6.3% | 4.4% | Health & Biotech Equities | 2013-10-21 | 0.08% | Fidelity | $1.01 | 2026-03-20 | $0.23 | 1.44% | 25.6 | 0.61 | 338 | 51.6% | View | 40% | 20% | 1099 | $69.12 | $72.68 | $70.15 | $71.03 | 47.69 | View | View | View | View | View | View | A | A+ | |||||||||||
| FBT | First Trust NYSE Arca Biotechnology Index Fund | Equity | $2,545,840 | 4.0% | 57,040.0 | $214.87 | -2.55% | 0.8% | 4.5% | 32.7% | 12.0% | 6.2% | Health & Biotech Equities | 2006-06-19 | 0.55% | N/A | $0.00 | 2024-12-13 | $1.17 | 0.00% | 26.7 | 0.68 | 31 | 41.5% | View | 40% | 20% | 1099 | $204.13 | $220.90 | $213.04 | $217.41 | 55.46 | View | View | View | View | View | View | B+ | B- | |||||||||||
| ARKG | ARK Genomic Revolution ETF | Equity | $1,304,300 | 17.4% | 2,537,675.0 | $34.00 | -2.16% | 8.6% | 12.2% | 57.1% | 1.5% | -15.9% | Health & Biotech Equities | 2014-10-31 | 0.75% | N/A | $0.00 | 2021-12-29 | $0.38 | 0.00% | N/A | 1.75 | 33 | 61.0% | View | 40% | 20% | 1099 | $26.86 | $34.58 | N/A | N/A | 64.84 | View | View | View | View | View | View | A | C+ | |||||||||||
| Click Here to Join to ETF Database Pro for 14 Days Free, Export This Data & So Much More | ||||||||||||||||||||||||||||||||||||||||||||||||||||
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...